Zeo ScientifiX (ZEOX) Assets Average (2013 - 2026)
Zeo ScientifiX (ZEOX) posted quarterly Assets Average of $3.2 million for Q2 2026, up 116.31% year-over-year from $1.5 million in Q2 2025, and up 57.56% quarter-over-quarter from $2.0 million in Q1 2026.
Zeo ScientifiX (ZEOX) Assets Average (2013 - 2026) Analysis & Trends
Zeo ScientifiX's Assets Average history runs 13 years deep, the most recent figure standing at $3.2 million for Q2 2026.
- In Q2 2026, Assets Average rose 116.31% year-over-year to $3.2 million; the TTM figure through Apr 2026 stood at $3.2 million (up 116.31% YoY), while the FY2025 annual figure was $1.6 million, down 28.36% from the prior year.
- Assets Average for Q2 2026 stood at $3.2 million, up from $2.0 million in the prior quarter.
- The five-year high for Assets Average was $5.3 million in Q1 2023, with the low at $1.5 million in Q2 2025.
- The 5-year median for Assets Average is $2.2 million (2022), against an average of $2.5 million.
- The sharpest annual moves came in 2023 and 2024: Assets Average soared 162.17% in 2023, then plunged 50.43% in 2024.
- Zeo ScientifiX's Assets Average stood at $4.4 million in 2022, then slumped by 40.2% to $2.6 million in 2023, then decreased by 26.23% to $1.9 million in 2024, then fell by 17.73% to $1.6 million in 2025, then soared by 103.11% to $3.2 million in 2026.
- Business Quant data shows ZEOX's Assets Average at $3.2 million in Q2 2026, $2.0 million in Q1 2026, and $1.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Zeo ScientifiX | 11.02 Mn | 9.17 Mn | 2.06 Mn | 3.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 3.23 Mn |
| Jan 31, 2026 | 2.05 Mn |
| Oct 31, 2025 | 1.59 Mn |
| Jul 31, 2025 | 1.54 Mn |
| Apr 30, 2025 | 1.49 Mn |
| Jan 31, 2025 | 1.60 Mn |
| Oct 31, 2024 | 1.93 Mn |
| Jul 31, 2024 | 2.08 Mn |
| Apr 30, 2024 | 2.18 Mn |
| Jan 31, 2024 | 2.61 Mn |
| Oct 31, 2023 | 2.62 Mn |
| Jul 31, 2023 | 2.90 Mn |
| Apr 30, 2023 | 3.83 Mn |
| Jan 31, 2023 | 5.26 Mn |
| Oct 31, 2022 | 4.38 Mn |
| Jul 31, 2022 | 2.39 Mn |
| Apr 30, 2022 | 2.15 Mn |
| Jan 31, 2022 | 2.01 Mn |
| Oct 31, 2021 | 1.82 Mn |
| Jul 31, 2021 | 1.51 Mn |